Erythropoietin-responsive sites in normal and malignant human lung tissues.
Preliminary findings of various types of globin expressed in the respiratory bronchiolar and alveolar epithelium prompted us to compare the expression of erythropoietin (Epo) and its receptor (EpoR) in normal (healthy) human lung tissues with that in malignant lung tissues. The expression of Epo and EpoR was examined at the transcriptional and protein levels in normal and malignant lung tissues by reverse transcription-PCR, western blot, and immunohistochemical analyses. EpoR mRNA, but not Epo mRNA, was detected in all samples. In normal tissues, EpoR was detected in the mesothelium, chondrocytes, alveolar cells, vascular endothelial cells, smooth muscle fibers, macrophages, and neutrophils, while in malignant foci, the cancer cells of five malignant types showed various intensities of EpoR immunoreactivity. The pattern of staining of EpoR protein was generally stronger in the malignant tissues than in the normal samples. Phosphorylation of the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK-ERK1/2) was frequently seen in malignant cells, but not in the normal tissues, with the exception of macrophages. Based on the expression of Epo and EpoR mRNA with the EpoR in almost all cell components in normal tissues, we suggest that the normal lung may produce various types of globin through the autocrine and/or paracrine role of Epo. When the Epo signal is upregulated by hypoxic stress, the normal cells appear to transform into malignant cells and proliferate through activated MAPK signaling.
Yasuda
Yoshiko
Y
Division 1, Department of Anatomy, Kinki University School of Medicine, Osakasayama, Osaka 589-8511, Japan. y1126yas@med.kindai.ac.jp
Hara
Satoshi
S
Hirohata
Takeshi
T
Koike
Eiji
E
Yamasaki
Harufumi
H
Okumoto
Katsumi
K
Hoshiai
Hiroshi
H
D019898:Autocrine Communication / Q000502:physiology; D015153:Blotting, Western; D002471:Cell Transformation, Neoplastic; D004921:Erythropoietin / Q000378:metabolism* / Q000502:physiology; D005914:Globins / Q000096:biosynthesis; D006801:Humans; D000860:Hypoxia / Q000473:pathology; D007150:Immunohistochemistry; D008168:Lung / Q000166:cytology / Q000378:metabolism* / Q000473:pathology; D008175:Lung Neoplasms / Q000378:metabolism* / Q000473:pathology; D020935:MAP Kinase Signaling System / Q000502:physiology; D019899:Paracrine Communication / Q000502:physiology; D012333:RNA, Messenger / Q000378:metabolism; D017467:Receptors, Erythropoietin / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015854:Up-Regulation
D012333:RNA, Messenger; D017467:Receptors, Erythropoietin; D004921:Erythropoietin; D005914:Globins